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Carotid endarterectomy in octogenarians: Does
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and Jay Hammerling, Toledo, Ohio
Objective: Carotid endarterectomy (CEA) is proven to be the most effective treatment for symptomatic carotid artery
stenosis of 50% or greater and asymptomatic carotid stenosis of 60% or greater. Although the prevalence of carotid artery
disease increases with age, most prospective and randomized trials have excluded patients older than 80 years, implying
that they are either at higher procedural risk or have decreased life expectancy. Since advanced age (>80 years) has been
viewed as a “high-risk” indicator for CEA, age >80 years has been used as an indication for alternative treatment. The
study was conducted to determine if age >80 years is related to increased morbidity, mortality, and length of stay in
patients undergoing CEA.
Methods: In the 12-year period from 1993 to 2004, 2217 CEAs were performed in 1961 patients. Three hundred sixty
procedures were performed in 334 patients>80 years. Demographics, presentation, risk factors, operative outcome, and
survival were analyzed. Contemporary literature was reviewed and the results summarized.
Results: In patients aged>80 years, compared with their younger cohort, there was no difference in stroke (1.1% vs 0.8%,
P  .333) but there was a higher operative mortality (1.9% vs 0.8%, P  .053). The combined stroke/death rate was
higher in octogenarians (3.1% vs 1.5%, P .041). This difference was due to the greater stroke/death rate in symptomatic
octogenarians vs asymptomatic octogenarians (6.0% vs 0.9%, P .007). The average postoperative length of stay was 3.2
 4.8 days for octogenarians compared with 2.4  3.5 days for their younger counterparts (P < .001). Thirty-seven
percent of the octogenarians were discharged on the first postoperative day vs 51% (P < .001), whereas 13% remained
hospitalized beyond 5 days vs 8% (P  .003). Although Kaplan-Meier survival curves show a higher mortality in
octogenarians, survival after CEA approaches that of the overall population. A summary of the contemporary literature
of CEA in 2204 patients >80 shows an operative stroke rate of 2.23% and death rate of 1.28%, with a combined
stroke/death rate of 3.51%.
Conclusion: CEA is a safe and effective procedure in the octogenarian. The combined stroke/death rate is increased in
patients aged >80, indicating increased risk, predominantly in symptomatic patients. Although CEA risk in octogenar-
ians is higher compared with a younger cohort, outcomes remain within acceptable national guidelines and within
outcome measures known to confer benefit compared with best medical care. Therefore, the term “high risk” should not
be arbitrarily applied to patients reaching the 80-year threshold. This is confirmed by the contemporary literature.
(J Vasc Surg 2005;41:231-7.)Advanced age has been reported to be associated with
an increased risk of carotid endarterectomy (CEA).1,2
However, numerous recent series have documented that
elderly patients can be treated operatively for carotid dis-
ease with good results,3-30 so why another report?
Either because of the concern of excessive risk or de-
creased postprocedure life expectancy, patients aged 80
years have been excluded from national randomized trials
comparing CEA to best medical care.31-34 Because this
rapidly growing subgroup of patients was excluded from
these important clinical studies, elderly patients are often
labeled as being “high risk” for CEA, and medical care or
catheter-based carotid angioplasty and stenting (CAS) are
offered as preferred treatments for their carotid disease.
Best medical care, wherever evaluated, is not as effective
as CEA,31-34 and catheter-based intervention does not
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doi:10.1016/j.jvs.2004.11.021appear to be either effective or safer35-37 and in fact, is
associated with greater risks in the elderly. Proponents of
CAS have reported procedure-related morbidity and mor-
tality rates of 25% and 16% in patients 80 years.35,36 In
the lead-in phase of the Carotid Revascularization with
Endarterectomy vs Stent Trial (CREST), patients 80
suffered a 13% stroke/death rate after CAS.37
Considering the risk of best medical care and high
procedure-related morbidity of CAS in the octogenarian,
and with the recent US Food and Drug Administration
approval of a percutaneous device for CAS, a complete
review of CEA data in the Jobst Vascular Registry and the
literature of CEA in octogenarians was performed.
MATERIALS AND METHODS
The Jobst Vascular Registry prospectively records pa-
tients undergoing vascular procedures at The Toledo Hos-
pital. The data for all patients undergoing CEA from Jan-
uary 1993 to August 2004 were retrospectively reviewed.
The age, sex, medical history, length of stay (LOS), dispo-
sition, postoperative complications, and surgical outcomes
(postoperative stroke and death) were tabulated. Operative
mortality was defined as all deaths that could be attributed
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after the procedure or longer, or all deaths within 30 days
postprocedure, regardless of cause.
Patients were separated into those aged 80 and 80
years for the important procedure-related outcomes. The
age groups were then further analyzed with regard to
presentation and gender. Long-term survival curves were
developed for the two cohorts. Survival curves were devel-
oped based on the status of the patient (living or dead),
length of time from operation to death, and by age. Date of
death was determined by querying the Social Security
Death Index.
The preoperative evaluation consisted of a duplex ul-
trasound scan with the addition of four-vessel cerebral
arteriography in most patients. All CEAs were performed
by a single group of board certified vascular surgeons. Most
of the CEAs were performed under general anesthesia,
intraoperative shunting was used routinely, and the arteri-
otomy was closed with either an autologous vein or syn-
thetic patch. Postoperatively, patients were monitored in
the intensive care unit for the first 24 hours. In the absence
of complications, patients were discharged on the first
postoperative day and were seen in follow-up within 7 to 10
days of the operation.
The Fisher exact test was used to compare the rates
between the two age groups (80 and 80 years) for
categorical variables with two levels; otherwise, Pearson 2
analysis was used to evaluate the relationship between the
categorical variables and the two age groups. The Student t
test was used to compare the continuous variable means
Table I. Literature review of postoperative outcomes in ca
Author Year Dates Total
Schultz et al 1988 1973-1986 1
Meyer et al 1991 1971-1989
Favre et al 1994 1983-1990
Treiman et al 1992 1964-1990 1
Coyle et al 1994 1983-1992
Thomas et al 1996 1977-1994 1
Van Damme et al 1996 1980-1994 1
Hallett et al 1998 1970-1995
O’Hara et al 1998 1989-1995 1
Hoballah et al 1998 1988-1996
Wong et al 1998 1980-1997 1
Ting et al 2000 1993-1998
Salameh et al 2002 1994-1998
Metz et al 2002 1986-1999
Ommer et al 2001 1990-1999
Rockman et al 2003 1997-1999 1
Pruner et al 2003 1995-2000 3
Ozvath et al 2002 1990-2000 1
Cartier et al 2002 1990-2001
Harbaugh et al 2002 1992-2001 1
Varghese et al 2004 1990-2001
Literature Total 22
Current Series 1993-2004 3
Total 25
CEA, Carotid endarterectomy.between the two groups. Kaplan-Meier survival analysis wasalso used. P  .05 was considered significant. All statistical
analysis was performed using SPSS version 12 (SPSS, Inc).
A Medline literature search of CEA in octogenarians
during the past 20 years was performed. All manuscripts
that reported the results of CEA in patients aged80 years
were evaluated for procedure-related stroke and death and
are summarized (Table I). Manuscripts that referred to
“elderly” patients but did not distinguish between patients
80 years and those in their 70s were not included. Tran-
sient neurologic deficits were not tabulated because of the
inconsistency of reporting.
RESULTS
Demographic results. At Jobst Vascular Center,
2217 CEAs were performed in 1961 patients. There were
1627 patients who had 1857 CEAs in the 80 age group
and 334 patients had 360 CEAs in the 80 age group.
Fourteen patients who underwent the first CEA at 80
years and a subsequent CEA at80 years were included in
the 80 cohort. There were 967 (59.4%) men and 660
(40.6%) women in the 80 age group and 195 (58.4%)
men and 139 (41.6%) women in the 80 age group. The
average age was 68.7 years for the80 age group and 83.6
years for the 80 age group.
Risk factors for carotid artery disease are listed in Table
II. The younger patient cohort had significantly more
diabetic patients and active smokers. Presenting symptoms
and indications for operation are listed in Table III. Asymp-
tomatic patients outnumbered symptomatic patients in
both the younger and older populations, 62.7% and 58.6%,
endarterectomy in 80 year olds
Stroke Mortality Combined
0.7 1.0 1.7
5.9 0 5.9
7.1 1.9 8.9
2.0 1.6 3.8
0 1.3 1.3
4.2 1.8 6.0
0.8 2.3 3.1
19.2 0.0 19.2
1.6 1.8 3.2
2.4 0 2.4
2.1 0.7 2.8
1.7 5.1 6.8
2.4 0 2.4
0 3.1 3.1
1.3 2.6 3.9
1.9 0 1.9
1.7 1.4 3.1
2.4 0.0 2.4
1.4 1.4 2.8
0.7 0.7 1.4
8.8 0.0 8.8
2.23 1.28 3.51
1.1 1.9 3.1
2.08 1.37 3.45rotid
CEA
15
56
56
83
79
13
29
26
82
41
41
59
42
32
76
61
45
25
72
37
34
04
60
64respectively. Stroke or focal hemispheric ischemia (or both)
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respectively. The category other includes nonspecific neu-
rologic presentations such as changes in retinal examina-
tions and visual disturbances other than amaurosis fugax
and dizziness.
Postoperative stroke. Table IV summarizes the out-
come of CEA by age group and presentation. Fourteen
strokes occurred in the 80 group (0.8%) and four (1.1%)
strokes in patients80 (P .333). There was no difference
in postoperative stroke rates between the age groups overall
or when stratified by presenting symptoms. No difference
in stroke outcome was noted when age groups were strat-
ified according to presentation or gender.
Operative mortality. Procedure-related mortality
was low for both age groups; however, a trend was noted
toward increased mortality in the octogenarians (.8% vs
1.9%; P  .053) (Table IV). When stratified by neurologic
presentation, procedure-related mortality was low in all
asymptomatic patients. Mortality was, however, signifi-
cantly different between symptomatic and asymptomatic
patients in the 80 age group (P  .007) and between
Table II. Risk factors
Risk Factors 80 (n  1857) (%)
Coronary artery disease 979 (52.7)
Hypertension 1384 (74.5)
Diabetes mellitus 563 (30.3)
Current smoking 488 (26.3)
n, Number of carotid operations.
Table III. Patient presentation
Symptoms 80 (n  1857)(%
Asymptomatic 1164 (62.7)
Stroke 184 (9.9)
Transient ischemic attack 297 (16.0)
Amaurosis fugax 173 (9.3)
Vertebrobasilar 3 (0.2)
Other 36 (1.9)
n, Number of carotid operations.
Table IV. Postoperative outcomes
Outcome
Overall
80 (n  1857)
(%)
80 (n  360)
(%)
8
Post-op stroke 14 (0.8) 4 (1.1)
Operative mortality 15 (0.8) 7 (1.9)
Combined stroke/
death
28 (1.5) 11 (3.1)*
n, Number of carotid operations.
*P  .041.
†P  .01.
‡P  .006.symptomatic older patients and all other patients (P .001). No difference in the postoperative death rate was
noted when age groups were stratified by gender, regard-
less of presentation.
Combined stroke/death. The combined stroke/
death rate in the 80 year patient group was 1.5% (28/
1857) compared with 3.1% (11/360) in the 80 age
group (P .041) (Table IV). The older and younger pa-
tients operated on for asymptomatic disease had similar
stroke/death rates, 0.9% (2/211) and 1.4% (16/1164),
respectively. The stroke/death rate difference resulted
from the higher mortality and resultant higher stroke/
death rate in symptomatic octogenarians, which was 6.0%
(9/149) compared with 1.7% (12/693) in symptomatic
patients 80 years (P  .006). No gender difference in
combined stroke/death rate was noted, regardless of pre-
sentation.
LOS, disposition, and complications. LOS can be
separated into two timeframes. Postoperative LOS mea-
sures the time from operation to discharge, whereas total
LOS is the time from admission to discharge. The average
postoperative LOS was 2.4  3.5 days for the group aged
80 (n  360) (%) P
185 (51.4) .343
264 (73.3) .339
69 (19.2) .001
23 (6.4) .001
80 (n  360) (%) P
211 (58.6) .082
38 (10.6) .384
71 (19.7) .050
32 (8.9) .445
(0) .588
8 (2.2) .424
Symptomatic Asymptomatic
693)
)
80 (n  149)
(%)
80 (n  1164)
(%)
80 (n  211)
(%)
.9) 3 (2.0) 8 (0.7) 1 (0.5)
.9) 6 (4.0)† 9 (0.8) 1 (0.5)
.7) 9 (6.0)‡ 16 (1.4) 2 (0.9))0 (n 
(%
6 (0
6 (0
12 (180 compared with 3.2  4.8 days for patients 80 (P 
ure m
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and 4.0  4.7 days for the 80 age group (P  .005). Of
the 80 age group, 51% were discharged on the first
postoperative day vs 37% of the80 age group (P .001).
Moreover, 13% of octogenarians remained hospitalized
beyond 5 days vs 8% of those 80 years old (P  .003).
Overall, the 80 age group had significantly longer stays
compared with the younger cohort.
Disposition is divided into four categories: discharge to
home, rehabilitation facility, or extended care facility
(ECF), and death. Accurate disposition was not available
on 10.1% of patients in the 80 age group or 8.1% in the
80 age group. In the80 age group, 86.2% patients were
discharged to home, 0.5% went to rehabilitation, 3.0%
went to an ECF, and 0.2% died (in-hospital mortality). In
the 80 age group, 79.2% were discharged to home, 1.9%
went to rehabilitation, 10.6% went to an ECF, and 0.3%
died (in-hospital mortality).
Table V shows the complications of the two age
groups, and no difference was observed.
Survival curve analysis. The survival curves for both
age groups after CEA are plotted and graphed in the figure.
Median survival after operation for patients was 11.7 years
in the 80 age group and 6.6 years in the 80 age group.
The respective means are 8.6 and 6.6 with standard error of
0.12 and 0.28 (P  .03). As the mean age of our CEA
patients in the80 age group was 83.5 years, these survival
curves compare favorably to the normal, age-adjusted pop-
ulations.38
Literature review. The literature review of CEA in the
elderly yielded 21 reports that provided stroke and death
data on patients 80 years old (Table I). A total of 2204
procedures were performed, with a stroke rate of 2.23%, an
operative mortality of 1.28%, and a combined stroke/death
rate of 3.51%. With the addition of the patients in this
series, the number of CEAs increased to 2564, the opera-
tive stroke rate adjusted to 2.08%, the death rate to 1.37%,
and the combined stroke/death rate to 3.45%.
DISCUSSION
It seems intuitive that elderly patients would have a
higher associated procedure-related morbidity and mortal-
ity than younger patients for most any operative procedure
Table V. Complications
Complication 80 (n1857)(%
Bleeding 53 (2.9)
Re-operation 53 (2.9)
Arrhythmia 27 (1.45)
Myocardial infarction 14 (0.8)
Renal failure 10 (0.5)
Pneumonia 8 (0.4)
Congestive heart failure 7 (0.4)
Combined complication* 109 (5.9)
n, Number of carotid operations.
*Data represent combined complications per procedure, where each procedbecause of their associated comorbidities. In 1989, Fisheret al1 reviewed Medicare claim files from New England and
reported that CEA mortality increased with age. This was
especially apparent in the octogenarians, where they found
more than a fourfold increase in the adjusted odds of death
compared to patients aged 65 to 69. The increased risk of
poor outcome was especially apparent in low-volume hos-
pitals (40 CEAs/year). Unfortunately, a large segment of
their sample was derived from low-volume hospitals. When
patients with carotid atherosclerotic disease are treated, it
has become clear that high procedure-related complication
rates eliminate the potential benefit of the procedure, no
matter what assumptions are made regarding the proce-
dure’s subsequent efficacy or the morbidity of best medical
management alone.
It was gratifying in this series to find no difference in
procedure-related mortality and no difference in proce-
dure-related stroke in octogenarians compared with the
younger cohort. The results are especially gratifying in the
asymptomatic patients, who showed a combined stroke/
death rate of 0.9%. The combined stroke/death rate was
higher in symptomatic patients 80 (P  .006); however,
in absolute terms, even elderly symptomatic patients had
outcomes that compared favorably with results from ran-
domized trials that evaluated the younger cohort of pa-
tients31-34 and published guidelines.39 The symptomatic
cohort of elderly patients had a similar procedure-related
stroke rate compared with those who were asymptomatic
(P  .194).
The results of symptomatic octogenarians in this series
are not different than those observed in randomized trials
of younger patients,31, 33 indicating that even symptomatic
octogenarians benefited from CEA compared with the best
medical care. The higher procedure-related mortality is
likely related to the instability of their systemic atheroscle-
rosis, as most of their deaths were nonstroke cardiovascular
etiologies.
In follow-up, elderly patients had a higher subsequent
mortality compared with younger patients (Fig). This
would be generally expected. It is interesting to note that
the subsequent mortality in our elderly cohort was no
different than that of the general population, considering
that the mean age of our 80 cohort was 83.5 years at the
time of operation. Their median survival rate after opera-
80 (n360) (%) P
16 (4.4) .081
15 (4.2) .126
7 (1.9) .309
4 (1.1) .333
2 (0.65) .604
4 (1.1) .116
3 (0.8) .213
31 (8.6) .58
ay be associated with multiple complications.)tion was 6.3 years. O’Hara and colleagues4 demonstrated
ge gr
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going CEA, who also had a mean age of 83 at the time of
CEA. However, when analyzing mortality related to renal
and pulmonary function, they found that patients who had
normal renal function and no chronic obstructive pulmo-
nary disease (COPD) had a 5-year survival of 60%, whereas
very few if any patients with elevated serum creatinine levels
and COPD survived 5 years. Associated serious comorbidi-
ties would be expected to compromise survival of all age
groups.
Appropriate questions regarding elderly patients un-
dergoing CEA are:
1. Why should elderly patients have a higher associated
mortality from an operation involving only the skin and
subcutaneous tissues?
2. Why should elderly patients have a higher risk of stroke
from CEA?
It appears that the mortality issue is related to associ-
ated comorbidities. Early studies demonstrated the in-
creased mortality associated with age.1 Inexperience with
the operation also appeared to be a major factor in earlier
Survival curves for 80 and 80 areports, however.1 In the more contemporary series, whichfrequently included high-volume institutions with vascular
specialists performing the procedures, mortality rates were
not higher in octogenarians than would be anticipated for
the general population. Although multisystem comorbidity
is associated with increased mortality,3,4 this would be
anticipated in patients of any age.
The concern that elderly patients have a higher risk of
CEA-related stroke has not been borne out, either in the
results of this review or the contemporary literature. It has
been shown that octogenarians have more severe intracra-
nial disease than their younger cohort. Rosenthal and col-
leagues40 demonstrated a fivefold increase in severe intra-
cranial disease in octogenarians compared with their
younger cohort. This observation is potentially important
in decision-making for procedures in older patients, as
ipsilateral intracranial arterial disease is an independent risk
factor for subsequent stroke in patients with symptomatic
internal carotid artery stenosis who are treated nonopera-
tively.41 Intracranial arterial disease is not, however, asso-
ciated with an increased risk of operative stroke in patients
undergoing CEA.41-43 Therefore, the additional risk asso-
oups postcarotid endarterectomy.ciated with intracranial disease in medically treated patients
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moderate or severe internal carotid artery stenosis.
An additional rationale for offering CEA to elderly
patients was clarified by Rosenthal et al7 when they com-
pared a nonrandomized group of 90 octogenarians under-
going CEA with 82 octogenarians with established carotid
disease who were not operated on but were treated with
best medical care. In a follow-up extending to 8 years, the
late stroke rate was 2% in CEA patients compared with 16%
in the nonoperated group. The morbidity and mortality of
stroke in these elderly patients was especially severe. The
mortality after stroke was approximately 50%, with all sur-
viving stroke patients requiring nursing home care and only
19% regaining any degree of ambulatory status.
It has been shown that elderly patients have a larger
atherosclerotic burden that leads to a more severe ischemic
insult when stroke occurs. The systemic inflammatory re-
sponse and the increase in inflammatory mediators corre-
late significantly with lesion volume and stroke severity.44
Although not specifically studied in elderly patients, it can
be easily understood how patients with larger atheroscle-
rotic volume and more severe intracranial disease have
more severe ischemia and poorer prognoses when stroke
occurs. Similar to the outcomes in patients suffering myo-
cardial infarction, the lesion size and elevated inflammatory
parameters in acute stroke patients are predictive of a poor
functional outcome.44
Despite the current results and the contemporary liter-
ature, there is a general perception of “high risk” associated
with CEA in elderly patients. This perception often leads to
recommendations for nonoperative treatment45 and more
recently, suggestions that CAS is preferable to CEA. As
pointed out by Rosenthal and colleagues7 initially and
suggested by randomized trial results subsequently, best
nonoperative care is not as effective as CEA.
Proponents of CAS have initially reported a 25% pro-
cedure-related morbidity rate35 and more recently, a 16%
stroke/death rate with CAS in octogenarians.36 Hobson et
al37 reported that the octogenarians treated with CAS as
lead-in patients in CREST had a 13% procedure-related
stroke/death rate. Clearly, by all available information,
CEA remains the safest and most effective management of
octogenarians with carotid atherosclerosis. Until random-
ized trial data suggest otherwise, CAS should be withheld
from this patient cohort because procedure-related mor-
bidity and mortality exceeds that of best medical care.
These observations are particularly pertinent, because epi-
demiologic data indicate that increasing numbers of pa-
tients requiring intervention for carotid atherosclerosis are
80 years old.46-48
In conclusion, octogenarian patients with carotid ath-
erosclerosis have good CEA outcomes that rival the
younger cohort. This series demonstrated that although
octogenarians have a higher stroke/death rate, the results
compare favorably with those reported in randomized tri-
als. The outcomes in the asymptomatic octogenarians were
especially gratifying.A contemporary literature review demonstrates consis-
tently good results in elderly patients undergoing CEA and
that favorable outcomes can be expected in patients who
are treated by experienced vascular specialists.
The combined stroke/death rate in octogenarians is
higher than their younger cohort, predominantly in symp-
tomatic patients, indicating increased risk. However, the
outcomes remain within acceptable national guidelines and
within outcome measures known to confer benefit com-
pared with best medical care. The term “high risk” should
therefore not be arbitrarily applied to patients reaching the
80-year threshold.
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